Melphalan, Prednisone, Thalidomide and Defibrotide in Relapsed Multiple Myeloma Patients
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and the efficacy of the association of Melphalan/
Prednisone/Thalidomide/Defibrotide (MPTD) as salvage treatment in advanced and refractory
myeloma patients. This association might further increase the response rate achieved by oral
MPT regimen